Chemours (NYSE: CC) SVP receives RSU grant, withholds shares for taxes

Rhea-AI Filing Summary

Chemours senior vice president Kristine M. Wellman reported equity compensation and related tax withholding transactions in company common stock. She received a grant of 25,708 restricted stock units, which are scheduled to vest in three equal annual installments beginning on March 1, 2027. To cover tax obligations from previously vesting RSUs and dividend equivalent units, 3,359 shares were automatically withheld at a price of $18.24 per share, and the disclosure states that no shares were sold in the market. After these changes, she reports direct ownership of 73,750.6057 shares, RSUs, and dividend equivalent units in total.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Wellman Kristine M

Role SVP, GC & Corp. Secretary

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	25,708	$0.00	--
Tax Withholding	Common Stock	3,359	$18.24	$61K

Holdings After Transaction: Common Stock — 73,750.606 shares (Direct)

Footnotes (1)

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027. Includes directly owned shares, RSUs and dividend equivalent units.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wellman Kristine M

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC & Corp. Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		3,359(1)	D	$18.24	48,042.6057	D
Common Stock	03/02/2026		A		25,708(2)	A	$0	73,750.6057(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.

3. Includes directly owned shares, RSUs and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Chemours (CC) report for Kristine Wellman?

Chemours reported that SVP Kristine Wellman received a grant of 25,708 restricted stock units and had 3,359 shares automatically withheld to cover tax obligations on vesting RSUs and dividend equivalent units. The filing notes that no shares were sold into the open market.

Were any Chemours (CC) shares sold by Kristine Wellman in this Form 4?

No open-market sales occurred. The Form 4 explains that 3,359 Chemours shares were automatically withheld solely to satisfy tax obligations on vesting restricted stock units and related dividend equivalent units. It explicitly states that no shares were sold, distinguishing this from discretionary selling activity.

How many Chemours (CC) restricted stock units were granted to Kristine Wellman?

Kristine Wellman was granted 25,708 restricted stock units of Chemours common stock. According to the disclosure, this RSU award is scheduled to vest in three equal annual installments starting on March 1, 2027, aligning the compensation with multi-year service and performance horizons.

When do Kristine Wellman’s new Chemours (CC) RSUs vest?

The new Chemours restricted stock units for Kristine Wellman are scheduled to vest in three equal annual installments beginning on March 1, 2027. This means portions of the 25,708-unit grant will vest over three years, reflecting a long-term incentive structure tied to future service.

What is Kristine Wellman’s Chemours (CC) share and unit ownership after these transactions?

After the reported transactions, Kristine Wellman holds 73,750.6057 Chemours-related units. The filing clarifies this figure includes directly owned common shares, restricted stock units, and dividend equivalent units, providing a consolidated view of her total reported beneficial interest in the company’s equity.

At what price were Chemours (CC) shares withheld for Kristine Wellman’s tax obligations?

The automatic tax-withholding transaction used a share price of $18.24. At that price, 3,359 Chemours common shares were withheld to satisfy tax obligations on vesting RSUs and dividend equivalent units, as described in the footnotes accompanying the Form 4 insider transaction report.